Abemaciclib | m-entrepreneurship.com

Product Name :
Abemaciclib

Search keywords :
Abemaciclib

drugId :
null

Target Vo:
Cyclin-dependent kinase 6

Target Vo Short Name :
CDK6

Moa_Name:
Cyclin-dependent kinase 6 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
Dana-Farber Cancer Institute

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:
Biliary Tract Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Hsp27 (Ser82) Antibody
RelB Antibody
BNIP3 Antibody: BNIP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to BNIP3. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts